Inner Mongolia Furui Medical Science Co., Ltd. (SHE: 300049)
China
· Delayed Price · Currency is CNY
37.43
-0.77 (-2.02%)
Nov 15, 2024, 3:04 PM CST
Inner Mongolia Furui Medical Science Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 130.4 | 101.56 | 97.89 | 95.47 | 61.91 | 43.39 | Upgrade
|
Depreciation & Amortization | 80.9 | 80.9 | 72.39 | 67.05 | 69.35 | 50.99 | Upgrade
|
Other Amortization | 9.32 | 9.32 | 3.92 | 1.17 | 1.55 | 0.11 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.82 | 0.82 | 1.86 | 3.46 | 6.93 | -0.01 | Upgrade
|
Asset Writedown & Restructuring Costs | 4.71 | 4.71 | 0 | - | 3.35 | 8.18 | Upgrade
|
Loss (Gain) From Sale of Investments | -2.53 | -2.53 | -4.12 | -5.74 | 1.6 | 12.88 | Upgrade
|
Provision & Write-off of Bad Debts | -3.06 | -3.06 | 6.58 | 8.95 | 1.83 | -10.82 | Upgrade
|
Other Operating Activities | -32.38 | 76.45 | 49.1 | 54.9 | 31.57 | 59.71 | Upgrade
|
Change in Accounts Receivable | -24.6 | -24.6 | -94.93 | -85 | 45.69 | 69.52 | Upgrade
|
Change in Inventory | -4.62 | -4.62 | -3.09 | 4.17 | 11.02 | -0.57 | Upgrade
|
Change in Accounts Payable | 68.82 | 68.82 | 66.76 | 57.31 | -28.99 | 45.71 | Upgrade
|
Operating Cash Flow | 224.9 | 304.89 | 189.46 | 222.55 | 200.15 | 256.23 | Upgrade
|
Operating Cash Flow Growth | -20.21% | 60.92% | -14.87% | 11.19% | -21.89% | 227.04% | Upgrade
|
Capital Expenditures | -193.95 | -189.23 | -90.78 | -79.61 | -109.74 | -66.29 | Upgrade
|
Sale of Property, Plant & Equipment | 6.5 | 2.73 | 1.86 | 2.01 | 2.67 | 0 | Upgrade
|
Cash Acquisitions | -18.74 | 0.95 | 0.62 | -0.12 | - | -0.81 | Upgrade
|
Divestitures | 2.86 | 0.83 | - | - | 0.7 | 6.37 | Upgrade
|
Investment in Securities | 13.75 | -7.01 | 2.84 | -116.28 | 68.74 | -68.22 | Upgrade
|
Other Investing Activities | 3.19 | 41.3 | 17.01 | 11.44 | 5.56 | 3.83 | Upgrade
|
Investing Cash Flow | -186.39 | -150.43 | -68.45 | -182.56 | -32.07 | -125.12 | Upgrade
|
Short-Term Debt Issued | - | 16.33 | 2.81 | 47.97 | 115.32 | - | Upgrade
|
Long-Term Debt Issued | - | - | - | - | - | 40 | Upgrade
|
Total Debt Issued | 16.33 | 16.33 | 2.81 | 47.97 | 115.32 | 40 | Upgrade
|
Short-Term Debt Repaid | - | -11.99 | -51.13 | -69.89 | -109.54 | - | Upgrade
|
Long-Term Debt Repaid | - | -9.5 | -11.36 | -14.24 | - | -71.75 | Upgrade
|
Total Debt Repaid | -22.52 | -21.49 | -62.49 | -84.13 | -109.54 | -71.75 | Upgrade
|
Net Debt Issued (Repaid) | -6.19 | -5.16 | -59.68 | -36.16 | 5.77 | -31.75 | Upgrade
|
Issuance of Common Stock | 52.31 | - | - | 26.6 | 0.2 | - | Upgrade
|
Common Dividends Paid | - | -53.42 | -71.41 | -1.95 | -3.76 | - | Upgrade
|
Other Financing Activities | -79.97 | -78.57 | 4.56 | 4.85 | -0.82 | -4.05 | Upgrade
|
Financing Cash Flow | -33.85 | -137.14 | -126.54 | -6.65 | 1.4 | -35.8 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.76 | 13.06 | 12.01 | -28.52 | -0.66 | 1.55 | Upgrade
|
Net Cash Flow | 5.42 | 30.38 | 6.49 | 4.82 | 168.83 | 96.85 | Upgrade
|
Free Cash Flow | 30.96 | 115.66 | 98.69 | 142.94 | 90.41 | 189.93 | Upgrade
|
Free Cash Flow Growth | -68.63% | 17.20% | -30.96% | 58.11% | -52.40% | - | Upgrade
|
Free Cash Flow Margin | 2.33% | 10.02% | 9.78% | 15.91% | 11.20% | 22.84% | Upgrade
|
Free Cash Flow Per Share | 0.12 | 0.44 | 0.38 | 0.55 | 0.35 | 0.74 | Upgrade
|
Cash Interest Paid | - | - | - | - | - | 2.97 | Upgrade
|
Cash Income Tax Paid | 115.26 | 102.31 | 89.39 | 52.05 | 86.11 | 73.43 | Upgrade
|
Levered Free Cash Flow | -13.64 | 63.94 | 34.29 | 102.67 | 63.17 | 269.09 | Upgrade
|
Unlevered Free Cash Flow | -12.97 | 64.5 | 35.28 | 104.12 | 65.18 | 270.95 | Upgrade
|
Change in Net Working Capital | 72.62 | -24.86 | 86.63 | 5.85 | -16.3 | -197.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.